Published in Ann Surg on November 01, 2007
fMRI and Appetite-Related Hormones Pre and Post Obesity Surgery | NCT01583725
The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery. Diabetes Care (2010) 2.64
Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) (2009) 2.28
Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes (2011) 2.23
Meal patterns, satiety, and food choice in a rat model of Roux-en-Y gastric bypass surgery. Am J Physiol Regul Integr Comp Physiol (2009) 1.72
The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology (2012) 1.70
Role of the foregut in the early improvement in glucose tolerance and insulin sensitivity following Roux-en-Y gastric bypass surgery. Am J Physiol Gastrointest Liver Physiol (2011) 1.68
Meal-induced hormone responses in a rat model of Roux-en-Y gastric bypass surgery. Endocrinology (2010) 1.64
Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency. Diabetes (2013) 1.64
Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost. J Gastrointest Surg (2009) 1.56
Association of ghrelin receptor promoter polymorphisms with weight loss following Roux-en-Y gastric bypass surgery. Obes Surg (2012) 1.50
Effect of weight loss by diet or gastric bypass surgery on peptide YY3-36 levels. Ann Surg (2009) 1.47
Do Incretins play a role in the remission of type 2 diabetes after gastric bypass surgery: What are the evidence? Obes Surg (2008) 1.45
Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol (2011) 1.44
Metabolic surgery: the role of the gastrointestinal tract in diabetes mellitus. Nat Rev Endocrinol (2010) 1.37
An expanded view of energy homeostasis: neural integration of metabolic, cognitive, and emotional drives to eat. Physiol Behav (2009) 1.35
Superior appetite hormone profile after equivalent weight loss by gastric bypass compared to gastric banding. Obesity (Silver Spring) (2010) 1.29
Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass procedure: a review. J Am Diet Assoc (2010) 1.28
Conjugated bile acids associate with altered rates of glucose and lipid oxidation after Roux-en-Y gastric bypass. Obes Surg (2012) 1.24
Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol (2010) 1.23
Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery. PLoS One (2009) 1.22
Mechanisms of glucose homeostasis after Roux-en-Y gastric bypass surgery in the obese, insulin-resistant Zucker rat. Ann Surg (2009) 1.20
Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg (2010) 1.20
Longitudinal changes in pancreatic and adipocyte hormones following Roux-en-Y gastric bypass surgery. Diabetologia (2008) 1.19
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity. Gut Liver (2012) 1.16
GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents. Am J Physiol Regul Integr Comp Physiol (2014) 1.16
Brain regulation of appetite and satiety. Endocrinol Metab Clin North Am (2008) 1.15
Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes (Lond) (2010) 1.13
Diabetes and weight in comparative studies of bariatric surgery vs conventional medical therapy: a systematic review and meta-analysis. Obes Surg (2014) 1.12
Bariatric surgery: the challenges with candidate selection, individualizing treatment and clinical outcomes. BMC Med (2013) 1.10
Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients. Diabetes (2013) 1.09
Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol (2009) 1.06
Obesity and appetite control. Exp Diabetes Res (2012) 1.05
Obesity, gut hormones, and bariatric surgery. World J Surg (2009) 1.04
The importance of the gut microbiota after bariatric surgery. Nat Rev Gastroenterol Hepatol (2012) 1.04
Physiological adaptations to weight loss and factors favouring weight regain. Int J Obes (Lond) (2015) 1.04
The short chain fatty acid propionate stimulates GLP-1 and PYY secretion via free fatty acid receptor 2 in rodents. Int J Obes (Lond) (2014) 1.03
Minireview: finding the sweet spot: peripheral versus central glucagon-like peptide 1 action in feeding and glucose homeostasis. Endocrinology (2009) 1.03
Could the mechanisms of bariatric surgery hold the key for novel therapies? report from a Pennington Scientific Symposium. Obes Rev (2011) 1.02
Intestinal GLP-1 and satiation: from man to rodents and back. Int J Obes (Lond) (2015) 1.00
Hypertrophy dependent doubling of L-cells in Roux-en-Y gastric bypass operated rats. PLoS One (2013) 0.99
The effect of laparoscopic gastric banding surgery on plasma levels of appetite-control, insulinotropic, and digestive hormones. Obes Surg (2008) 0.99
Type 2 diabetes mellitus--current therapies and the emergence of surgical options. Nat Rev Endocrinol (2011) 0.97
Regulation of glucose homeostasis by GLP-1. Prog Mol Biol Transl Sci (2014) 0.97
The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab (2015) 0.97
Incretin hormones and the satiation signal. Int J Obes (Lond) (2013) 0.97
Increased postprandial energy expenditure may explain superior long term weight loss after Roux-en-Y gastric bypass compared to vertical banded gastroplasty. PLoS One (2013) 0.97
Obesity surgery and gut-brain communication. Physiol Behav (2011) 0.97
Modulation of taste responsiveness and food preference by obesity and weight loss. Physiol Behav (2012) 0.97
Roux-en-Y gastric bypass in rats increases sucrose taste-related motivated behavior independent of pharmacological GLP-1-receptor modulation. Am J Physiol Regul Integr Comp Physiol (2011) 0.95
Altered brain activity in severely obese women may recover after Roux-en Y gastric bypass surgery. Int J Obes (Lond) (2013) 0.95
GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility. Am J Physiol Endocrinol Metab (2012) 0.95
Role of Gut-Related Peptides and Other Hormones in the Amelioration of Type 2 Diabetes after Roux-en-Y Gastric Bypass Surgery. ISRN Endocrinol (2012) 0.94
Intestinal feedback signaling and satiety. Physiol Behav (2011) 0.94
The physiology underlying Roux-en-Y gastric bypass: a status report. Am J Physiol Regul Integr Comp Physiol (2014) 0.93
Effects of RYGB on energy expenditure, appetite and glycaemic control: a randomized controlled clinical trial. Int J Obes (Lond) (2013) 0.93
PYY3-36 and oxyntomodulin can be additive in their effect on food intake in overweight and obese humans. Diabetes (2010) 0.92
The role of bile acids in reducing the metabolic complications of obesity after bariatric surgery: a systematic review. Int J Obes (Lond) (2015) 0.92
Gastrointestinal hormones and bariatric surgery-induced weight loss. Obesity (Silver Spring) (2013) 0.91
Changes in gastrointestinal hormones and leptin after Roux-en-Y gastric bypass surgery. JPEN J Parenter Enteral Nutr (2011) 0.91
Preoperative β-cell function in patients with type 2 diabetes is important for the outcome of Roux-en-Y gastric bypass surgery. J Physiol (2015) 0.91
Gut microbial communities modulating brain development and function. Gut Microbes (2012) 0.90
Bariatric surgery to unload the stressed heart: a metabolic hypothesis. Am J Physiol Heart Circ Physiol (2012) 0.90
Adiposopathy and bariatric surgery: is 'sick fat' a surgical disease? Int J Clin Pract (2009) 0.90
Roux-en-Y gastric bypass: effects on feeding behavior and underlying mechanisms. J Clin Invest (2015) 0.90
Peripheral mechanisms in appetite regulation. Gastroenterology (2014) 0.90
Wishing for deburdening through a sustainable control after bariatric surgery. Int J Qual Stud Health Well-being (2011) 0.89
GLYCEMIC BEHAVIOR IN 48 HOURS POSTOPERATIVE PERIOD OF PATIENTS WITH TYPE 2 DIABETES MELLITUS AND NON DIABETIC SUBMITTED TO BARIATRIC SURGERY. Arq Bras Cir Dig (2015) 0.89
Roux-en-Y gastric bypass operation in rats. J Vis Exp (2012) 0.89
Vagal innervation of the hepatic portal vein and liver is not necessary for Roux-en-Y gastric bypass surgery-induced hypophagia, weight loss, and hypermetabolism. Ann Surg (2012) 0.89
The gut hormones in appetite regulation. J Obes (2011) 0.88
Sodium and water handling after gastric bypass surgery in a rat model. Surg Obes Relat Dis (2010) 0.88
Appetite regulation and weight control: the role of gut hormones. Nutr Diabetes (2012) 0.88
Acute peripheral GLP-1 receptor agonism or antagonism does not alter energy expenditure in rats after Roux-en-Y gastric bypass. Physiol Behav (2013) 0.87
Ghrelin and metabolic surgery. Int J Pept (2010) 0.87
Is the Roux limb a determinant for meal size after gastric bypass surgery? Obes Surg (2010) 0.87
The future role of gut hormones in the treatment of obesity. Ther Adv Chronic Dis (2014) 0.86
Striatal dopamine homeostasis is altered in mice following Roux-en-Y gastric bypass surgery. ACS Chem Neurosci (2014) 0.86
Mechanism Underlying the Weight Loss and Complications of Roux-en-Y Gastric Bypass. Review. Obes Surg (2016) 0.85
Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? World J Gastroenterol (2014) 0.85
The sum of many parts: potential mechanisms for improvement in glucose homeostasis after bariatric surgery. Curr Diab Rep (2014) 0.85
Gastric bypass surgery restores meal stimulation of the anorexigenic gut hormones glucagon-like peptide-1 and peptide YY independently of caloric restriction. Surg Endosc (2011) 0.84
The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis. Am J Physiol Regul Integr Comp Physiol (2014) 0.84
Vertical sleeve gastrectomy activates GPBAR-1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice. Hepatology (2016) 0.84
Mechanisms responsible for excess weight loss after bariatric surgery. J Diabetes Sci Technol (2011) 0.84
Impact of Weight Loss Surgery on Esophageal Physiology. Gastroenterol Hepatol (N Y) (2015) 0.84
Reversible hyperphagia and obesity in rats with gastric bypass by central MC3/4R blockade. Obesity (Silver Spring) (2014) 0.83
Mechanisms of activation of mouse and human enteroendocrine cells by nutrients. Gut (2014) 0.82
Weight regain after gastric bypass: etiology and treatment options. Gland Surg (2016) 0.81
Gut hormone pharmacology of a novel GPR119 agonist (GSK1292263), metformin, and sitagliptin in type 2 diabetes mellitus: results from two randomized studies. PLoS One (2014) 0.81
The role of sweet taste in satiation and satiety. Nutrients (2014) 0.81
Peripheral mechanisms in the control of appetite and related experimental therapies in obesity. Regul Pept (2009) 0.81
Effects of leptin replacement alone and with exendin-4 on food intake and weight regain in weight-reduced diet-induced obese rats. Am J Physiol Endocrinol Metab (2012) 0.81
The use of functional MRI to study appetite control in the CNS. Exp Diabetes Res (2012) 0.81
Bariatric surgery and diabetes remission: Who would have thought it? Indian J Endocrinol Metab (2015) 0.80
Postprandial insulin secretion after gastric bypass surgery: the role of glucagon-like peptide 1. Diabetes (2011) 0.80
Metabolic surgery-principles and current concepts. Langenbecks Arch Surg (2011) 0.80
Pylorus preserving loop duodeno-enterostomy with sleeve gastrectomy - preliminary results. BMC Surg (2014) 0.80
Short- and midterm results between laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy for the treatment of morbid obesity. J Obes (2013) 0.80
Peptide YY and glucagon-like peptide-1 contribute to decreased food intake after Roux-en-Y gastric bypass surgery. Int J Obes (Lond) (2016) 0.80
Link Between Increased Satiety Gut Hormones and Reduced Food Reward After Gastric Bypass Surgery for Obesity. J Clin Endocrinol Metab (2015) 0.79
Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med (2007) 18.45
Gut hormone PYY(3-36) physiologically inhibits food intake. Nature (2002) 8.30
Bariatric surgery and long-term cardiovascular events. JAMA (2012) 7.11
Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects. N Engl J Med (2012) 6.19
Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med (2003) 5.83
Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease. Kidney Int (2009) 4.61
Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg (2006) 4.30
AMP-activated protein kinase plays a role in the control of food intake. J Biol Chem (2004) 3.84
Metabolic surgery profoundly influences gut microbial-host metabolic cross-talk. Gut (2011) 3.42
Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol (2009) 3.14
Kisspeptin-54 stimulates the hypothalamic-pituitary gonadal axis in human males. J Clin Endocrinol Metab (2005) 3.08
Weight loss, cardiovascular risk factors, and quality of life after gastric bypass and duodenal switch: a randomized trial. Ann Intern Med (2011) 2.90
Gut hormones and the regulation of energy homeostasis. Nature (2006) 2.53
The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res (2005) 2.19
Post-embryonic ablation of AgRP neurons in mice leads to a lean, hypophagic phenotype. FASEB J (2005) 2.03
Obese patients after gastric bypass surgery have lower brain-hedonic responses to food than after gastric banding. Gut (2013) 2.01
Ghrelin increases energy intake in cancer patients with impaired appetite: acute, randomized, placebo-controlled trial. J Clin Endocrinol Metab (2004) 1.97
Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg (2006) 1.97
Gastric bypass increases energy expenditure in rats. Gastroenterology (2009) 1.79
Sustained appetite improvement in malnourished dialysis patients by daily ghrelin treatment. Kidney Int (2009) 1.78
An increase in kisspeptin-54 release occurs with the pubertal increase in luteinizing hormone-releasing hormone-1 release in the stalk-median eminence of female rhesus monkeys in vivo. Endocrinology (2008) 1.76
Design, synthesis, and biological evaluation of the first selective nonpeptide AT2 receptor agonist. J Med Chem (2004) 1.74
Gastric bypass surgery for obesity decreases the reward value of a sweet-fat stimulus as assessed in a progressive ratio task. Am J Clin Nutr (2012) 1.74
The role of bile after Roux-en-Y gastric bypass in promoting weight loss and improving glycaemic control. Endocrinology (2012) 1.70
Effects of exercise on gut peptides, energy intake and appetite. J Endocrinol (2007) 1.61
Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization. J Clin Invest (2014) 1.58
Subcutaneous oxyntomodulin reduces body weight in overweight and obese subjects: a double-blind, randomized, controlled trial. Diabetes (2005) 1.52
Erythropoietin administration in humans causes a marked and prolonged reduction in circulating hepcidin. Haematologica (2009) 1.49
Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively. Endocrinology (2005) 1.49
Neuropeptide S stimulates the hypothalamo-pituitary-adrenal axis and inhibits food intake. Endocrinology (2006) 1.49
Improved diagnostic accuracy for neuroendocrine neoplasms using two chromogranin A assays. Clin Endocrinol (Oxf) (2012) 1.47
Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women. J Clin Endocrinol Metab (2007) 1.46
Gastric bypass reduces fat intake and preference. Am J Physiol Regul Integr Comp Physiol (2011) 1.44
Laparoscopic biliopancreatic diversion/duodenal switch or laparoscopic Roux-en-Y gastric bypass for super-obesity-weight loss versus side effects. Surg Obes Relat Dis (2010) 1.43
Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg (2010) 1.39
Ghrelin, peptide YY, glucose-dependent insulinotropic polypeptide, and hunger responses to a mixed meal in anorexic, obese, and control female adolescents. J Clin Endocrinol Metab (2005) 1.38
Gut peptides in the regulation of food intake and energy homeostasis. Endocr Rev (2006) 1.38
Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab (2009) 1.38
Oxyntomodulin suppresses appetite and reduces food intake in humans. J Clin Endocrinol Metab (2003) 1.35
The gut hormones PYY 3-36 and GLP-1 7-36 amide reduce food intake and modulate brain activity in appetite centers in humans. Cell Metab (2011) 1.35
Vitamin status after bariatric surgery: a randomized study of gastric bypass and duodenal switch. Am J Clin Nutr (2009) 1.35
High expression of complement components in omental adipose tissue in obese men. Obes Res (2003) 1.34
Leptin inhibits the anti-CD3-driven proliferation of peripheral blood T cells but enhances the production of proinflammatory cytokines. J Leukoc Biol (2002) 1.33
Gut hypertrophy after gastric bypass is associated with increased glucagon-like peptide 2 and intestinal crypt cell proliferation. Ann Surg (2010) 1.32
Peripheral oxyntomodulin reduces food intake and body weight gain in rats. Endocrinology (2004) 1.31
Gastrointestinal satiety signals. Annu Rev Physiol (2008) 1.27
Chronic subcutaneous administration of kisspeptin-54 causes testicular degeneration in adult male rats. Am J Physiol Endocrinol Metab (2006) 1.26
The role of gut hormones and the hypothalamus in appetite regulation. Endocr J (2010) 1.24
Bowels control brain: gut hormones and obesity. Nat Rev Endocrinol (2010) 1.23
The gut hormone peptide YY regulates appetite. Ann N Y Acad Sci (2003) 1.22
Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg (2003) 1.20
Hypothalamic neuropeptides and the regulation of appetite. Neuropharmacology (2012) 1.20
Vagal sparing surgical technique but not stoma size affects body weight loss in rodent model of gastric bypass. Obes Surg (2010) 1.20
Constitutional thinness and lean anorexia nervosa display opposite concentrations of peptide YY, glucagon-like peptide 1, ghrelin, and leptin. Am J Clin Nutr (2007) 1.19
Surface area of the digestive tract - revisited. Scand J Gastroenterol (2014) 1.19
Stimulation of AT2 receptor exerts beneficial effects in stroke-prone rats: focus on renal damage. J Hypertens (2009) 1.18
Subcutaneous ghrelin enhances acute food intake in malnourished patients who receive maintenance peritoneal dialysis: a randomized, placebo-controlled trial. J Am Soc Nephrol (2005) 1.18
Gut Hormones and Appetite Control: A Focus on PYY and GLP-1 as Therapeutic Targets in Obesity. Gut Liver (2012) 1.16
Gut hormones and the control of appetite. Trends Endocrinol Metab (2004) 1.15
Characterization of ghrelin-like immunoreactivity in human plasma. J Clin Endocrinol Metab (2005) 1.14
Blockade of the neuropeptide Y Y2 receptor with the specific antagonist BIIE0246 attenuates the effect of endogenous and exogenous peptide YY(3-36) on food intake. Brain Res (2005) 1.14
Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia. Diabetes (2012) 1.13